Summary: Scientists have systematically evaluated the benefits and risks of GLP-1 medications, such as Ozempic and Zepbound, among more than 2 million users
Ihren Termin knnen sie schnell und bequem telefonisch oder jederzeit ber DOCTOLIB vereinbaren
doi: 10.3389/fphar.2025.1675552 Received 29 July 2025 Accepted 28 August 2025 Published 11 September 2025 Volume 16 - 2025 Edited by Claudia Manca, University of Cagliari, Italy Reviewed by Basveshwar Gawali, Washington University in St
Theyre often caused by blood disorders (like sickle cell anemia), liver disease, or infections
Results The study included 289,809 adults (median age 54.6 years, 65.2% female, 69.2% with type 2 diabetes)
What do you mean by that